Rx Propellant Unveils $100 Million Plan for Integrated Life Sciences Facility in Hyderabad.

Rx Propellant, a science and R&D infrastructure platform established by Actis and part of General Atlantic, will invest $100 million to develop a new large-format life sciences campus in Genome Valley in Hyderabad.

The announcement was made during the inaugural session of the 23rd edition of BioAsia 2026, which commenced in the city.

The project, positioned as part of the company’s long-term commitment to strengthening India’s life sciences ecosystem, will involve the phased development of more than one million square feet of advanced laboratory infrastructure over the next six years.

Planned as a single integrated campus comprising multiple blocks, the facility is set to become the largest life sciences campus in Genome Valley. It is being designed to cater to corporations seeking to lease space within a professionally managed campus equipped with resilient and well-supported infrastructure.